litlas
ログインアカウント作成

Richard B. Kim

1994–2024 年に発表

121
論文数
25,060
被引用数
86
h 指数
118
i10 指数

被引用数

Richard B. Kim の年別被引用数1979 年: 被引用 1 件1989 年: 被引用 1 件1995 年: 被引用 8 件1996 年: 被引用 2 件1997 年: 被引用 11 件1998 年: 被引用 22 件1999 年: 被引用 73 件2000 年: 被引用 79 件2001 年: 被引用 107 件2002 年: 被引用 171 件2003 年: 被引用 270 件2004 年: 被引用 383 件2005 年: 被引用 394 件2006 年: 被引用 371 件2007 年: 被引用 298 件2008 年: 被引用 310 件2009 年: 被引用 304 件2010 年: 被引用 288 件2011 年: 被引用 317 件2012 年: 被引用 290 件2013 年: 被引用 284 件2014 年: 被引用 189 件2015 年: 被引用 164 件2016 年: 被引用 160 件2017 年: 被引用 151 件2018 年: 被引用 147 件2019 年: 被引用 516 件2020 年: 被引用 529 件2021 年: 被引用 479 件2022 年: 被引用 386 件2023 年: 被引用 265 件2024 年: 被引用 418 件2025 年: 被引用 145 件2026 年: 被引用 3 件1980〜1988 年は被引用が無いため表示していません1990〜1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,303 件、この内訳の 28.2%中国: 引用元論文 612 件、この内訳の 7.5%ドイツ: 引用元論文 596 件、この内訳の 7.3%イギリス: 引用元論文 547 件、この内訳の 6.7%日本: 引用元論文 399 件、この内訳の 4.9%カナダ: 引用元論文 322 件、この内訳の 3.9%オランダ: 引用元論文 278 件、この内訳の 3.4%スイス: 引用元論文 230 件、この内訳の 2.8%フランス: 引用元論文 229 件、この内訳の 2.8%スウェーデン: 引用元論文 228 件、この内訳の 2.8%イタリア: 引用元論文 208 件、この内訳の 2.5%スペイン: 引用元論文 162 件、この内訳の 2%
0%28.2%その他 25.2%

機関

分野

  • Medicine58.6%
  • Pharmacology, Toxicology and Pharmaceutics16.3%
  • Biochemistry, Genetics and Molecular Biology14.6%
  • Computer Science2.3%
  • Immunology and Microbiology1.9%
  • Neuroscience1.9%
  • その他4.4%

トピック

  • Drug Transport and Resistance Mechanisms15%
  • Pharmacogenetics and Drug Metabolism8.9%
  • Pharmacological Effects and Toxicity Studies5.9%
  • HIV/AIDS drug development and treatment2.9%
  • Computational Drug Discovery Methods2.3%
  • Drug-Induced Hepatotoxicity and Protection1.7%
  • その他63.3%

共著者

全論文

検索で開く
  1. Membrane transporters in drug development

    著者: Kathleen M. Giacomini, Shiew‐Mei Huang, Donald Tweedie, Leslie Z. Benet, Kim L. R. Brouwer, Xiaoyan Chu, Amber Dahlin, Raymond Evers, Volker Fischer, Kathleen M. Hillgren, Keith Hoffmaster, Toshihisa Ishikawa, Dietrich Keppler, Richard B. Kim, Caroline A. Lee, Mikko Niemi, Joseph W. Polli, Yuicchi Sugiyama, Peter W. Swaan, Joseph A. Ware, Stephen H. Wright, Sook Wah Yee, Maciej J. Zamek‐Gliszczynski, Lei Zhang - Nature Reviews Drug Discovery 2010 被引用: 3,319

  2. SLC transporters as therapeutic targets: emerging opportunities

    著者: Lawrence Lin, Sook Wah Yee, Richard B. Kim, Kathleen M. Giacomini - Nature Reviews Drug Discovery 2015 被引用: 838

  3. HLADQA1*05 genotype predicts anti‐drug antibody formation and loss of response during infliximab therapy for inflammatory bowel disease

    著者: Aze Wilson, Celeste Peel, Qian Wang, A. Demetri Pananos, Richard B. Kim - Alimentary Pharmacology & Therapeutics 2019 被引用: 96

  4. Targeted next generation sequencing as a tool for precision medicine

    著者: Markus Gulilat, Tyler Lamb, Wendy A. Teft, Jian Wang, Jacqueline S. Dron, John F. Robinson, Rommel G. Tirona, Robert A. Hegele, Richard B. Kim, Ute I. Schwarz - BMC Medical Genomics 2019 被引用: 96

  5. Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease

    著者: Aze Wilson, Wendy A. Teft, Bridget L. Morse, Yun‐Hee Choi, Sarah Woolsey, Marianne K. DeGorter, Robert A. Hegele, Rommel G. Tirona, Richard B. Kim - Digestive Diseases and Sciences 2015 被引用: 95

  6. Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn’s disease

    著者: Aze Wilson, Ahmed A. Almousa, Wendy A. Teft, Richard B. Kim - Scientific Reports 2020 被引用: 69

  7. High oncostatin M predicts lack of clinical remission for patients with inflammatory bowel disease on tumor necrosis factor α antagonists

    著者: Angela Guo, Cameron Ross, Nilesh Chande, Jamie Gregor, Terry Ponich, Reena Khanna, Michael Sey, Melanie Beaton, Brian Yan, Richard B. Kim, Aze Wilson - Scientific Reports 2022 被引用: 40

  8. Drug and Bile Acid Transporters in Rosuvastatin Hepatic Uptake: Function, Expression, and Pharmacogenetics

    著者: Richard Ho, Rommel G. Tirona, Brenda F. Leake, Hartmut Glaeser, Wooin Lee, Christopher J. Lemke, Yi Wang, Richard B. Kim - Gastroenterology 2006 被引用: 610

  9. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events

    著者: Richard B. Kim, Bridget L. Morse, Ognjenka Djurdjev, Mila Tang, Norman Muirhead, Brendan J. Barrett, Daniel T. Holmes, François Madore, Catherine M. Clase, Claudio Rigatto, Adeera Levin, Mohsen Agharazii, Joanne Blouin, France Samson, Ayub Akbarii, Judy O. Cheesman, Jennilea Courtney, Sabrina Hamer, Edita Delic, Valerie Cronin, Paul E. Barré, Jeffrey A. Golden, Brendan J. Barrett, Elizabeth Langille, Sylvia Adams, Janet Morgan, Catherine M. Clase, Cathy Moreau, Susan M. Cooper, Brian Forzley, Susan Caron, Shauna Granger, Susan Valley, Helen Sather, Serge Cournoyer, Lorraine Ménard, Michèle Roy, Hélène Skidmore, Dolores Beaudry, Janis M. Dionne, Josephine Chow, Valla Sahraei, Sandra Donnelly, Niki Dacouris, Rosa M. Marticorena, Brenda R. Hemmelgarn, Sharon Gulewich, Troy Hamilton, Paul Keown, Nadia Zalunardo, Daniel A. Rogers, Reena Tut, M. Paquette, Rossitta Yung, Adeera Levin, Nancy Ferguson, Mila Tang, Helen Chiu, Kathleen Carlson, Lina Sioson, Taylor Perry, Zainab Sheriff, Naama Rozen, Charmaine E. Lok, Michelle Cross, Cathy Forrester, Alexandra Cotoi, François Madore, Manon Maltais, Louise Moist, Kerri Gallo, Sarah Langford, Leah Slamen, Danielle Cram, Norman Muirhead, Mary Jeanne Edgar, Taylor Gray, Cameron Edgar, Karen E. GROENEWEG, Eileen M. McKinnon, Erin McRae, Kyla Blackie, Bharat Nathoo, Kimmy Lau, Malvinder S. Parmar, Sylvie Gélinas, Martine Leblanc, Lucie Lépine, Claudio Rigatto, Dolores Friesen, Steven D. Soroka, Susan Fleet, Jeanette Squires, Siva Thanamayooran, Michael Binder, Christine Hines, Brenda McNeil, Patrice McDougall, Howard Joy, Deborah Gillis ほか 12 名 - Kidney International 2016 被引用: 175

  10. Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance

    著者: Maciej J. Zamek‐Gliszczynski, Mitchell E. Taub, Paresh P. Chothe, Xiaoyan Chu, Kathleen M. Giacomini, Richard B. Kim, Adrian S. Ray, Sophie L. Stocker, Jashvant D. Unadkat, Matthias Wittwer, Cindy Q. Xia, Sook Wah Yee, Lei Zhang, Yan Zhang - Clinical Pharmacology & Therapeutics 2018 被引用: 229

  11. Human Skeletal Muscle Drug Transporters Determine Local Exposure and Toxicity of Statins

    著者: Michael J. Knauer, Bradley L. Urquhart, Henriette E. Meyer zu Schwabedissen, Ute I. Schwarz, Christopher J. Lemke, Brenda F. Leake, Richard B. Kim, Rommel G. Tirona - Circulation Research 2009 被引用: 224

  12. Fruit juices inhibit organic anion transporting polypeptide–mediated drug uptake to decrease the oral availability of fexofenadine

    著者: George K. Dresser, David G. Bailey, Brenda F. Leake, Ute I. Schwarz, Paul A. Dawson, David J. Freeman, Richard B. Kim - Clinical Pharmacology & Therapeutics 2002 被引用: 606

  13. Polymorphisms in OATP-C

    著者: Rommel G. Tirona, Brenda F. Leake, Gracia Merino, Richard B. Kim - Journal of Biological Chemistry 2001 被引用: 624

  14. Polymorphisms in Human Organic Anion-transporting Polypeptide 1A2 (OATP1A2)

    著者: Wooin Lee, Hartmut Glaeser, Layton H. Smith, Richard Roberts, Gilbert Moeckel, Guillermo Gervasini, Brenda F. Leake, Richard B. Kim - Journal of Biological Chemistry 2005 被引用: 362

  15. Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects

    著者: George K. Dresser, Ute I. Schwarz, G. Wilkinson, Richard B. Kim - Clinical Pharmacology & Therapeutics 2003 被引用: 261

  16. Inhibition of P-Glycoprotein–Mediated Drug Transport

    著者: Martin F. Fromm, Richard B. Kim, C. Michael Stein, G. Wilkinson, Dan M. Roden - Circulation 1999 被引用: 400

  17. Disrupted Bile Acid Homeostasis Reveals an Unexpected Interaction among Nuclear Hormone Receptors, Transporters, and Cytochrome P450

    著者: Erin G. Schuetz, Stephen C. Strom, Kazuto Yasuda, Valérie Lecureur, Mahfoud Assem, Cynthia Brimer, Jatinder K. Lamba, Richard B. Kim, Vinod Ramachandran, Bernard J. Komoroski, Raman Venkataramanan, Hongbo Cai, Christopher J. Sinal, Frank J. Gonzalez, John D. Schuetz - Journal of Biological Chemistry 2001 被引用: 391

  18. Importance of Pharmacokinetic Profile and Variability as Determinants of Dose and Response to Dabigatran, Rivaroxaban, and Apixaban

    著者: Inna Y. Gong, Richard B. Kim - Canadian Journal of Cardiology 2013 被引用: 199

  19. The Role of Next-Generation Sequencing in Pharmacogenetics and Pharmacogenomics

    著者: Ute I. Schwarz, Markus Gulilat, Richard B. Kim - Cold Spring Harbor Perspectives in Medicine 2018 被引用: 75

  20. Genetic Determinants of Response to Warfarin during Initial Anticoagulation

    著者: Ute I. Schwarz, Marylyn D. Ritchie, Yuki Bradford, Chun Li, Scott Dudek, Amy Frye-Anderson, Richard B. Kim, Dan M. Roden, C. Michael Stein - New England Journal of Medicine 2008 被引用: 581

  21. Nuclear Receptors and the Regulation of Drug‐Metabolizing Enzymes and Drug Transporters: Implications for Interindividual Variability in Response to Drugs

    著者: Bradley L. Urquhart, Rommel G. Tirona, Richard B. Kim - The Journal of Clinical Pharmacology 2007 被引用: 377

  22. The Effect of Common Polymorphisms of the β2-Adrenergic Receptor on Agonist-Mediated Vascular Desensitization

    著者: Victor Dishy, Gbenga G. Sofowora, Hong‐Guang Xie, Richard B. Kim, Daniel W. Byrne, C. Michael Stein, Alastair J.J. Wood - New England Journal of Medicine 2001 被引用: 361

  23. A 12 R -lipoxygenase in human skin: Mechanistic evidence, molecular cloning, and expression

    著者: William E. Boeglin, Richard B. Kim, Alan Brash - National Academy of Sciences, Proceedings of the National Academy of Sciences 1998 被引用: 177

  24. Fexofenadine and Rosuvastatin Pharmacokinetics in Mice with Targeted Disruption of Organic Anion Transporting Polypeptide 2B1

    著者: Samantha Medwid, Mandy M. J. Li, Michael J. Knauer, Kathleen Lin, Sara E. Mansell, Crystal L. Schmerk, Catherine Zhu, Katelyn E. Griffin, Mohamed D. Yousif, George K. Dresser, Ute I. Schwarz, Richard B. Kim, Rommel G. Tirona - Drug Metabolism and Disposition 2019 被引用: 53